Rebastinib
CAS: 1020172-07-9
Ref. TM-T2640
| 2mg | 47.00 € | ||
| 5mg | 68.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 169.00 € | ||
| 50mg | 247.00 € | ||
| 100mg | 370.00 € | ||
| 200mg | 557.00 € | ||
| 1ml*10 (DMSO) | 83.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Rebastinib
Synonyms:
- DCC2036, DCC 2036, DCC-2036
- N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea
- Dcc-2036
CAS:
Description:
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
553.59
Formula:
C30H28FN7O3
Purity:
99.84%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2640 Rebastinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
